| Open Document File Size: 69,00 KBShare Result on Facebook
City DUBLIN / / Company Eisai Inc. / AEs / Astex Pharmaceuticals Inc. / Janssen-Cilag International NV / Astex Pharmaceuticals Astex Pharmaceuticals / / Continent North America / / Country Turkey / Russia / United States / Brazil / Canada / Korea / China / Mexico / India / / Currency USD / / Event FDA Phase / Funding / Business Partnership / / IndustryTerm Treatment of Acute Myeloid Leukemia / pharmaceutical / / MedicalCondition cancer / disease / secondary acute myeloid leukemia / myelodysplastic syndromes / shortness of breath / neutropenia / thrombocytopenia / fever / About Acute Myeloid Leukemia Acute myeloid leukemia / febrile neutropenia / tiredness / infections / anemia / / MedicalTreatment chemotherapy / / Organization World Health Organization / European Commission / European Union / / Person S.J. Manuso / / Position chairman and chief executive officer / physician / / Product cytarabine / DACOGEN / DACO-016 / DACOGEN® (decitabine) / / ProvinceOrState California / / Technology chemotherapy / / URL http /
SocialTag |
September 28, 2012 DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia New Treatment Offers Clinically Significant Benefit for Patients DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -